Literature DB >> 15470491

Prediction of relapse of acute myeloid leukemia in allogeneic transplant recipients by marrow CD34+ donor cell chimerism analysis.

C Scheffold, M Kroeger, M Zuehlsdorf, J Tchinda, G Silling, G Bisping, M Stelljes, T Buechner, W E Berdel, J Kienast.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15470491     DOI： 10.1038/sj.leu.2403507

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

1.  Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation.

Authors:  Anne Bouvier; Jérémie Riou; Sylvain Thépot; Aurélien Sutra Del Galy; Sylvie François; Aline Schmidt; Corentin Orvain; Marie-Hélène Estienne; Alban Villate; Damien Luque Paz; Laurane Cottin; Bénédicte Ribourtout; Annaëlle Beucher; Yves Delneste; Norbert Ifrah; Valérie Ugo; Mathilde Hunault-Berger; Odile Blanchet
Journal:  Leukemia       Date:  2019-11-25       Impact factor: 11.528

2.  Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation.

Authors:  Martin Bornhäuser; Uta Oelschlaegel; Uwe Platzbecker; Gesine Bug; Karin Lutterbeck; Michael G Kiehl; Johannes Schetelig; Alexander Kiani; Thomas Illmer; Markus Schaich; Catrin Theuser; Brigitte Mohr; Cornelia Brendel; Axel A Fauser; Stefan Klein; Hans Martin; Gerhard Ehninger; Christian Thiede
Journal:  Haematologica       Date:  2009-11       Impact factor: 9.941

3.  Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Authors:  Hans C Lee; Rima M Saliba; Gabriela Rondon; Julianne Chen; Yasmeen Charafeddine; L Jeffrey Medeiros; Gheath Alatrash; Borje S Andersson; Uday Popat; Partow Kebriaei; Stefan Ciurea; Betul Oran; Elizabeth Shpall; Richard Champlin
Journal:  Biol Blood Marrow Transplant       Date:  2015-07-14       Impact factor: 5.742

4.  Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia.

Authors:  Klaus Wethmar; Svenja Matern; Eva Eßeling; Linus Angenendt; Heike Pfeifer; Monika Brüggemann; Patrick Stelmach; Simon Call; Jörn C Albring; Jan-Henrik Mikesch; Christian Reicherts; Christoph Groth; Christoph Schliemann; Wolfgang E Berdel; Georg Lenz; Matthias Stelljes
Journal:  Bone Marrow Transplant       Date:  2020-01-30       Impact factor: 5.483

Review 5.  Minimal residual disease in acute myeloid leukaemia.

Authors:  Christopher S Hourigan; Judith E Karp
Journal:  Nat Rev Clin Oncol       Date:  2013-06-25       Impact factor: 66.675

6.  Chimerism analysis in peripheral blood using indel quantitative real-time PCR is a useful tool to predict post-transplant relapse in acute leukemia.

Authors:  N Jacque; S Nguyen; J-L Golmard; M Uzunov; A Garnier; V Leblond; J-P Vernant; D Bories; N Dhédin
Journal:  Bone Marrow Transplant       Date:  2014-11-10       Impact factor: 5.483

7.  Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial.

Authors:  U Platzbecker; M Wermke; J Radke; U Oelschlaegel; F Seltmann; A Kiani; I-M Klut; H Knoth; C Röllig; J Schetelig; B Mohr; X Graehlert; G Ehninger; M Bornhäuser; C Thiede
Journal:  Leukemia       Date:  2011-09-02       Impact factor: 11.528

Review 8.  Analysis of Subset Chimerism for MRD-Detection and Pre-Emptive Treatment in AML.

Authors:  Julia-Annabell Georgi; Sebastian Stasik; Martin Bornhäuser; Uwe Platzbecker; Christian Thiede
Journal:  Front Oncol       Date:  2022-02-17       Impact factor: 6.244
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.